Peru - Spaans - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

ferquim s.a. - droguerÍa - comprimido - por comprimido - - glibenclamida

Chili - Spaans - ISPC (Instituto de Salud Pública de Chile)

fresenius kabi chile ltda. - adalimumab - sin formulas

Peru - Spaans - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

qualipharm s.r.ltda. - bisulfato de clopidogrel; - tableta recubierta - por vial mg - clopidogrel

Chili - Spaans - ISPC (Instituto de Salud Pública de Chile)

roche chile ltda. - baloxavir marboxil - sin formulas

Europese Unie - Spaans - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - combinaciones - teva ácido acetilsalicílico/clopidogrel está indicado para la prevención de eventos aterotrombóticos en pacientes adultos ya tomando tanto clopidogrel como ácido acetilsalicílico (asa). clopidogrel/ácido acetilsalicílico teva es una combinación a dosis fija de los productos medicinales para la continuación de la terapia en:sin elevación del segmento st síndrome coronario agudo (angina inestable o no‑q onda infarto de miocardio), incluyendo pacientes sometidos a colocación de un stent siguientes coronaria percutánea interventionst elevación del segmento infarto agudo de miocardio en los pacientes tratados médicamente elegibles para la terapia trombolítica.

Cuba - Spaans - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

cristÁlia productos quÍmicos farmacÉuticos ltda., brasil. - lamotrigina - comprimido - 100,00 mg

Chili - Spaans - ISPC (Instituto de Salud Pública de Chile)

glaxosmithkline chile farmacÉutica ltda. - sin formulas

Chili - Spaans - ISPC (Instituto de Salud Pública de Chile)

glaxosmithkline chile farmacÉutica ltda. - ambrisentan - sin formulas

Europese Unie - Spaans - EMA (European Medicines Agency)

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Europese Unie - Spaans - EMA (European Medicines Agency)

swedish orphan biovitrum ab (publ) - anakinra - arthritis, rheumatoid; covid-19 virus infection - inmunosupresores - la artritis reumatoide (ar)kineret está indicado en adultos para el tratamiento de los signos y síntomas de la ar en combinación con metotrexato, con una respuesta inadecuada a metotrexato solo. covid-19kineret is indicated for the treatment of coronavirus disease 2019 (covid-19) in adult patients with pneumonia requiring supplemental oxygen (low- or high-flow oxygen) who are at risk of progressing to severe respiratory failure determined by plasma concentration of soluble urokinase plasminogen activator receptor (supar) ≥ 6 ng/ml. periodic fever syndromeskineret is indicated for the treatment of the following autoinflammatory periodic fever syndromes in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above:cryopyrin-associated periodic syndromes (caps)kineret is indicated for the treatment of caps, including:neonatal-onset multisystem inflammatory disease (nomid) / chronic infantile neurological, cutaneous, articular syndrome (cinca)muckle-wells syndrome (mws)familial cold autoinflammatory syndrome (fcas)familial mediterranean fever (fmf)kineret is indicated for the treatment of familial mediterranean fever (fmf). kineret debe administrarse en combinación con colchicina, si es apropiado. still’s diseasekineret is indicated in adults, adolescents, children and infants aged 8 months and older with a body weight of 10 kg or above for the treatment of still’s disease, including systemic juvenile idiopathic arthritis (sjia) and adult-onset still’s disease (aosd), with active systemic features of moderate to high disease activity, or in patients with continued disease activity after treatment with non-steroidal anti-inflammatory drugs (nsaids) or glucocorticoids. kineret can be given as monotherapy or in combination with other anti-inflammatory drugs and disease-modifying antirheumatic drugs (dmards).